抗がん療法開発における薬物再利用のネクサスとして,ユビキチン特異ペプチダゼ22 (USP22) を標的とする
Saad Ali Alshehri1, Abdulrhman Alsayari1, Mohammad Abohassan2
1Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Journal of receptor and signal transduction research
|August 23, 2025
まとめ
この研究は,がんの進行と治療抵抗における重要な標的であるUSP22を阻害する潜在的な再用薬としてエルゴタミンを特定しています. 新しいがん治療法の開発には,さらなる実験的検証が推奨されます.
科学分野:
- 腫瘍学
- コンピュータ化学
- 薬物の発見
背景:
- ユビキチン特異ペプチダゼ22 (USP22) は,様々ながんにおいて頻繁に過剰発現し,腫瘍の進行,転移,および治療抵抗性を引き起こす.
- USP22はDNA修復,細胞循環調節,がん幹細胞の維持など 重要な細胞過程で重要な役割を果たします
- USP22過剰発現の再発性および耐性腫瘍には新しい治療戦略が必要であり,薬物の再利用が魅力的なアプローチとなります.
研究 の 目的:
- USP22の阻害剤として再利用できるFDAが承認した薬を特定する.
- USP22の結合ポケットと特定の相互作用を持つ化合物を計算的にスクリーニングする.
主な方法:
- 分子ドッキングと分子ダイナミクス (MD) シミュレーションを組み合わせた統合計算ワークフローが採用されました.
- ドラッグバンクからFDAが承認した化合物の仮想スクリーニングが行われました.
- 全原子MDシミュレーション (300ns) とMM/PBSA計算を使用して,特定された化合物の安定性と結合相互作用を評価した.
主要な成果:
- エルゴタミンは,USP22結合ポケット内で高い結合親和性と特定の相互作用を示した.
- 薬動学的評価によると,エルゴタミンは抗がん治療に適した薬剤プロファイルを有している.
- MDシミュレーションとMM/PBSA分析により,USP22-エルゴタミン複合体の安定性と強度が確認され,抑制メカニズムに関する洞察が得られました.
結論:
- エルゴタミンはUSP22阻害剤として有意な可能性を示しています.
- エルゴタミンの有効性の実験的検証は,新しいがん治療薬としての開発に必要である.
さらに関連する動画
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
375
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020
10.1K
関連する概念動画
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K